SAN DIEGO—ResMed, a provider of digital health and cloud-connected medical devices that transform care for people with sleep apnea and other chronic respiratory diseases, announced the U.S. launch of the AirFit F40, an ultra-compact, full-face mask offering the comfort of smaller masks without sacrificing performance to help improve sleep apnea therapy compliance.
SAN DIEGO, California—ResMed launched its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined with digital technology to make it easier for health care providers to treat sleep apnea and to help patients start and stay on therapy.
SAN DIEGO—ResMed is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body. This voluntary field correction does not require a return of a mask with magnets unless the patient is contraindicated.
SAN DIEGO—ResMed announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open, the study found that COPD prevalence among those 25 years and older is expected to increase by 23% from 2020 to 2050, with the largest growth projected among women and within low- and middle-income countries.
SAN DIEGO, California—ResMed announced the acquisition of privately held Somnoware, a U.S. sleep and respiratory care diagnostics software.
Nearly every U.S. hospital and physician entity is more likely to refer patients to a post-acute care (PAC) provider that can support electronic data exchange, according to the latest leading independent survey on interoperability, commissioned by Brightree and MatrixCare, wholly owned subsidiaries of ResMed.
A group of AAHomecare member companies aim to support the association’s public policy work by joining the new Legacy corporate partner tier. Companies now supporting the association at the new level are making an annual dues commitment of $125,000; they include Apria & Byram, ResMed & Brightree and Medline.
MARTINSRIED, Germany and LEIPZIG, Germany (August 2, 2022)—ResMed today announced the acquisition of Leipzig-based company mementor; the deal was completed Monday, Aug. 1. With this acquisition, ResMed strengthens its overall sleep portfolio in Germany with a digital solution for insomnia.
SAN DIEGO (June 30, 2022)—ResMed announced the promotion of Lucile Blaise to global president of Sleep & Respiratory Care, effective July 1, 2022.
SAN DIEGO & HILDESHEIM, Germany (June 14, 2022)—ResMed today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German provider of out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, a software and services investor.
AN DIEGO (March 15, 2022)—ResMed announced the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year, asked nearly 25,000 respondents in 12 countries what’s keeping them up at night and the results aim to build awareness of the critical role good sleep plays in physical and mental health.
SAN DIEGO (August 26, 2021)—ResMed announced the promotion of Bobby Ghoshal to president of ResMed’s software as a service (SaaS) business, effective immediately. Raj Sodhi will be leaving full-time employment at ResMed, effective Sept. 1.
BIRMINGHAM, Alabama (August 19, 2021)—A surge in demand for sleep and respiratory devices in the wake of a Philips Respironics recall has created “an unprecedented increase in demand” for Resmed devices, the company’s CEO said—but supply chain and freight limitations are making it hard for the company to keep up. Nonetheless, the company could realize $300 million-$350 million in unplanned additional revenue in fiscal year 2022, he said.
SAN DIEGO (August 16, 2021)—ResMed, a provider of digital health and sleep apnea treatment, launched AirSense 11, available first in the United States, the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea start and stay on therapy to treat and manage obstructive sleep apnea.
SAN DIEGO (March 16, 2021)—ResMed, a digital health company, announced the results of a nationwide survey of 1,000 adults, which revealed that for half of Americans, stress over the past year is negatively impacting the quality of their sleep—and many are ignoring sleep challenges that could point to a larger underlying health concern.
WASHINGTON, D.C. (February 26, 2021)—ResMed’s Vice President of Global Government Affairs and Market Access, Larissa D’Andrea, has accepted the open position on the Executive Committee for AAHomecare. The open position became available following another merger within the industry, and the association reached out to the talented and committed advocate to fill the position. D’Andrea most recently sat on the board of directors for the association.
SAN DIEGO, (September 1, 2020)—ResMed announced the launch of its AirTouch N20 nasal mask, the company’s first CPAP nasal mask with a memory foam cushion and softest nasal mask ever.
SAN DIEGO (May 18, 2020)— ResMed has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients receive the care they need from home.
